Clinical Trial Update: Omega-3 Fatty Acids for Autism Treatment [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial to evaluate omega-3 fatty acids for autism completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: University of California, San Francisco | Conditions: Autism | Phase 2 | Status: COMPLETED | Results posted: 2012-08-31